Shopping Cart
- Remove All
- Your shopping cart is currently empty
Catumaxomab, a trifunctional IgG2 antibody with mouse and rat heavy and light chain components, targets human EpCAM and CD3 receptors. Its Fc region exhibits affinity for FcγRI (CD64), FcγRIIA (CD32a), and FcγRIII (CD16), making it a valuable tool in epithelial cancer anti-tumor research [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Catumaxomab, a trifunctional IgG2 antibody with mouse and rat heavy and light chain components, targets human EpCAM and CD3 receptors. Its Fc region exhibits affinity for FcγRI (CD64), FcγRIIA (CD32a), and FcγRIII (CD16), making it a valuable tool in epithelial cancer anti-tumor research [1] [2]. |
In vitro | Catumaxomab (0-5 ng/mL; 3-7 days) significantly inhibited the growth of FaDu tumor spheroids co-cultured with PBMCs in a dose-dependent manner [2]. |
Cas No. | 509077-98-9 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.